Cresco Labs investment Idea
Fundamental side of the idea:
For the full year of 2020, Cresco saw a whopping 271% year-over-year increase in revenue to $476 million. The company's retail revenue for the year grew to $202 million, up 316% year over year. Much of the credit goes to its Sunnyside retail platform, which, according to the management, generated average revenue per store of $3.6 million. Cresco has 10 Sunnyside stores in the new emerging cannabis market of Illinois. ) Its fourth-quarter (ended Dec. 31, 2020) revenue also jumped a massive 292% year over year to $162.3 million.
Another quarter of positive adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) net of biological assets of $50 million is an impressive jump from $2.8 million in the year-ago quarter. It also reflects how well the company has been handling its operating expenses. Cresco's 2020 was a reflection of what's to come in the next few years, according to the management.
Technical side of the idea:
Since the price has hit an all time high(22CAD), it has been decreasing / and retraced to 0,61 Fibu level. As long as the price is Rebounding exactly on 0,61 Multiple times we should consider that there is a big Possibility for the Price to Move higher. I am expecting that the price will continue to increase to 80USD in the next two years, after breaking the 1,61 Fibu level ( which is going to be the new resistance ).
If you have Questions, you can Always Contact me !
Best Regards.
S.Sadki
For the full year of 2020, Cresco saw a whopping 271% year-over-year increase in revenue to $476 million. The company's retail revenue for the year grew to $202 million, up 316% year over year. Much of the credit goes to its Sunnyside retail platform, which, according to the management, generated average revenue per store of $3.6 million. Cresco has 10 Sunnyside stores in the new emerging cannabis market of Illinois. ) Its fourth-quarter (ended Dec. 31, 2020) revenue also jumped a massive 292% year over year to $162.3 million.
Another quarter of positive adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) net of biological assets of $50 million is an impressive jump from $2.8 million in the year-ago quarter. It also reflects how well the company has been handling its operating expenses. Cresco's 2020 was a reflection of what's to come in the next few years, according to the management.
Technical side of the idea:
Since the price has hit an all time high(22CAD), it has been decreasing / and retraced to 0,61 Fibu level. As long as the price is Rebounding exactly on 0,61 Multiple times we should consider that there is a big Possibility for the Price to Move higher. I am expecting that the price will continue to increase to 80USD in the next two years, after breaking the 1,61 Fibu level ( which is going to be the new resistance ).
If you have Questions, you can Always Contact me !
Best Regards.
S.Sadki
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.